Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. 1999

C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
Medical Research Service, Seattle Veterans Affairs Medical Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine 98195, USA.

Neutrophils (polymorphonuclear neutrophils; PMN) and a redundant system of chemotactic cytokines (chemokines) have been implicated in the pathogenesis of the acute respiratory distress syndrome in patients with sepsis. PMN express two cell surface receptors for the CXC chemokines, CXCR1 and CXCR2. We investigated the expression and function of these receptors in patients with severe sepsis. Compared with normal donors, CXCR2 surface expression was down-regulated by 50% on PMN from septic patients (p < 0.005), while CXCR1 expression persisted. In vitro migratory responses to the CXCR1 ligand, IL-8, were similar in PMN from septic patients and normal donors. By contrast, the migratory response to the CXCR2 ligands, epithelial cell-derived neutrophil activator (ENA-78) and the growth-related oncogene proteins, was markedly suppressed in PMN from septic patients (p < 0.05). Ab specific for CXCR1 blocked in vitro migration of PMN from septic patients to IL-8 (p < 0.05), but not to FMLP. Thus, functionally significant down-regulation of CXCR2 occurs on PMN in septic patients. We conclude that in a complex milieu of multiple CXC chemokines, CXCR1 functions as the single dominant CXC chemokine receptor in patients with sepsis. These observations offer a potential strategy for attenuating adverse inflammation in sepsis while preserving host defenses mediated by bacteria-derived peptides such as FMLP.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating
D054360 Chemokine CXCL1 A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types. CXCL1 Chemokine,Chemokine (C-X-C Motif) Ligand 1,GROalpha Protein,Gro-alpha Protein,Growth-Related Oncogene alpha Protein,MGSA-alpha Chemokine,Melanoma Growth Stimulatory Activity, alpha Protein,Neutrophil-Activating Protein 3,CXCL1, Chemokine,Chemokine, CXCL1,Chemokine, MGSA-alpha,Gro alpha Protein,Growth Related Oncogene alpha Protein,MGSA alpha Chemokine,Neutrophil Activating Protein 3

Related Publications

C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
December 2001, The Journal of thoracic and cardiovascular surgery,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
May 2001, Brain research. Developmental brain research,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
October 2002, Blood,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
October 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
January 2016, PloS one,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
November 2006, Bioorganic & medicinal chemistry letters,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
January 2003, The Journal of allergy and clinical immunology,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
September 2012, Proceedings of the National Academy of Sciences of the United States of America,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
August 2004, Proceedings of the National Academy of Sciences of the United States of America,
C J Cummings, and T R Martin, and C W Frevert, and J M Quan, and V A Wong, and S M Mongovin, and T R Hagen, and K P Steinberg, and R B Goodman
June 2000, Genes and immunity,
Copied contents to your clipboard!